In 2025, Enbrel generated *** billion U.S. dollars of revenue in total. Enbrel is a biopharmaceutical product that is used to treat autoimmune diseases. It is marketed as a powder or a pre-mixed liquid. Previously, Enbrel was promoted by both Amgen and Pfizer in the United States and Canada. Since November 2016, the FDA has approved the expanded use of Enbrel as a drug to treat pediatric patients (ages 4-17) with chronic moderate-to-severe plaque psoriasis.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
Amgen, & U.S. Securities and Exchange Commission. (February 13, 2026). Revenue of Amgen's Enbrel by region from 2011 to 2025 (in million U.S. dollars) [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 31, 2026, from /statistics/312378/enbrel-global-revenues-by-region-amgen/
Amgen, und U.S. Securities and Exchange Commission. "Revenue of Amgen's Enbrel by region from 2011 to 2025 (in million U.S. dollars)." Chart. February 13, 2026. ÌÇÐÄÆƽâ°æ. Accessed July 31, 2026. /statistics/312378/enbrel-global-revenues-by-region-amgen/
Amgen, U.S. Securities and Exchange Commission. (2026). Revenue of Amgen's Enbrel by region from 2011 to 2025 (in million U.S. dollars). ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 31, 2026. /statistics/312378/enbrel-global-revenues-by-region-amgen/
Amgen, and U.S. Securities and Exchange Commission. "Revenue of Amgen's Enbrel by Region from 2011 to 2025 (in Million U.S. Dollars)." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 13 Feb 2026, /statistics/312378/enbrel-global-revenues-by-region-amgen/
Amgen & U.S. Securities and Exchange Commission, Revenue of Amgen's Enbrel by region from 2011 to 2025 (in million U.S. dollars) ÌÇÐÄÆƽâ°æ, /statistics/312378/enbrel-global-revenues-by-region-amgen/ (last visited July 31, 2026)
Revenue of Amgen's Enbrel by region from 2011 to 2025 (in million U.S. dollars) [Graph], Amgen, & U.S. Securities and Exchange Commission, February 13, 2026. [Online]. Available: /statistics/312378/enbrel-global-revenues-by-region-amgen/
